CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells

Cisplatin (cis-diamminedichloroplatinum II [CDDP] ) is a well-known chemotherapeutic drug that has been used for the treatment of various types of human cancers, including head and neck cancer. Cisplatin exerts anticancer effects by causing DNA damage, replication defects, transcriptional inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Chikuda, Junichiro, Otsuka, Kurataka, Shimomura, Iwao, Ito, Kagenori, Miyazaki, Hiroaki, Takahashi, Ryou-u, Nagasaki, Masahiro, Mukudai, Yoshiki, Ochiya, Takahiro, Shimane, Toshikazu, Shirota, Tatsuo, Yamamoto, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226407/
https://www.ncbi.nlm.nih.gov/pubmed/32244823
http://dx.doi.org/10.3390/cancers12040856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226407/
https://www.ncbi.nlm.nih.gov/pubmed/32244823
http://dx.doi.org/10.3390/cancers12040856

Ejemplares similares